JRNYS vs Pallas Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
People who want branded GLP-1s with coaching through insurance, and can accept learning the medication price only after a consultation.
- semaglutide
- Not confirmed for JRNYS.
- tirzepatide
- Not confirmed for JRNYS.
Before enrolling
The membership is overhead, not a medication price: it covers visits, monitoring and coaching, and the FAQ says medication pricing is confirmed only after a provider consultation
Desk Score
Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.
- semaglutide
- $199/mosee conditions
- tirzepatide
- $299/mosee conditions
Before enrolling
There is no month-to-month rung for either compounded molecule — the funnel renders no cadence selector — so the advertised “$199/mo average” is a single $597 charge every twelve weeks divided by three
Our review of Pallas Health gives it 87/100 (B+), while our review of JRNYS gives it 62/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
62/100
C
87/100
B+
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | JRNYS | Pallas Health |
|---|---|---|
| Semaglutide | Not confirmed for JRNYS. | $199/mosee conditionsFull plan terms$199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold) |
| Tirzepatide | Not confirmed for JRNYS. | $299/mosee conditionsFull plan terms$299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold) |
| Coverage | Not confirmed for JRNYS. | All 50 states + DC (async in 43; 7 states plus DC require one video visit) |
| Brand-name | Brand-name option listed | Brand-name option listed |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | People who want branded GLP-1s with coaching through insurance, and can accept learning the medication price only after a consultation. | Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one. |
| Desk Score | 62/100C | 87/100B+ |
The verdict
Desk pick — Pallas HealthPallas Health has the higher Desk Score, but JRNYS may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
People who want branded GLP-1s with coaching through insurance, and can accept learning the medication price only after a consultation.
Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs JRNYS
- CoreAge Rx vs Pallas Health
- Eden vs JRNYS
- Pallas Health vs Sesame Care
- JRNYS vs Vytora Health
- Eden vs Pallas Health
Or see the full comparison hub and the complete ranking.